CLICK TO EXPAND

News About DC

IN THIS DAY AND AGE, NEWS TRAVELS FASTER THAN EVER BEFORE.

And when it’s about Dunlap Codding, our team and our accomplishments, it all lands right here.
Dunlap Codding Director Jordan A. Sigale Quoted in Law360 on Michael Jordan Verdict
Posted Aug 27, 2015 at 11:42 am See More

Jordan Sigale was quoted in a Law360 article by Zachary Zagger on August 24, “Jordan Verdict A Warning For Advertisers On Image Use.”  The article commented on the verdict in Jordan et al. v. Dominick’s Finer Foods, LLC, in which lawsuit Jordan was awarded $8.9 million in damages by a jury “in a trial over a full-page advertisement in Sports Illustrated taken out in 2009 by former Chicago-area grocery chain Dominick’s Finer Foods LLC, now owned by Safeway Inc., without the superstar athlete’s approval.”  The ad offered a coupon for $2 off a steak and depicted and congratulated Jordan, saying “you’re a cut above the rest.”  Jordan’s likeness was used without his approval and he testified in trial that he does not take less than $10 million for advertising deals using his image or likeness, and that he would not have approved this use at any price because it was not in keeping with his strategy.

Sigale was quoted as saying the case forced the jury to decide what the true fair market value of the ad was in 2009 and that it says a lot about how a “jury of our peers” views the way in which we compensate people for their right of publicity.  He went on to observe, “While this jury was clearly comfortable with the notion that some people’s right of publicity can be extremely valuable, it wasn’t willing to completely side with Mr. Jordan.”  Dominick’s had argued that the fair market value was closer to $100,000.  Sigale noted that the jury didn’t award Jordan the full $10 million, but also didn’t go as low as Dominick’s sought.  

Dunlap Codding Shareholders Selected For Inclusion In The Best Lawyers In America® 2016
Posted Aug 17, 2015 at 22:17 pm See More

OKLAHOMA CITY, OKLAHOMA —August 17, 2015—Dunlap Codding is pleased to announce that Marc A. Brockhaus, Nicholas D. Rouse and Douglas J. Sorocco have been selected by attorney peers for inclusion in The Best Lawyers in America® 2016, the oldest and most respected peer–review publication in the legal profession.  Firm managing shareholder Nick Rouse said, “We’re delighted to be included in the publication.  We have always worked to provide excellent service and value to our clients and to uphold the reputation of our industry.”  

Marc Brockhaus was listed in The Best Lawyers in America® 2016 for Patent Law.  Marc leads Dunlap Codding’s Electrical Engineering & Systems group.  His practice includes all areas of intellectual property, including technology, computer and patent law, and extends to counseling, transactions, litigation, and prosecution before the United States Patent and Trademark Office.  He is ranked in the top band of Oklahoma’s top intellectual property practitioners by the highly regarded Chambers USA: America’s Leading Lawyers for Business. Marc has been an adjunct faculty member at the University Of Oklahoma College Of Law and received his J.D. and his Masters of Business Administration from the University of Oklahoma in 1997, where he was inducted into Beta Gamma Sigma.  He received his B.S. in Electrical Engineering from the University of Oklahoma in 1993. 

Nick Rouse, listed in The Best Lawyers in America® 2016 in the fields of Patent Law and Trademark Law, has served as Dunlap Codding’s managing shareholder since 2007 while continuing an active practice.  In its inaugural coverage of intellectual property law in Oklahoma, the highly regarded Chambers USA: America’s Leading Lawyers for Business ranked Nick in the top band of leading practitioners, and he continues to be ranked in the top band. Nick provides a broad range of patent counseling to clients ranging from individual inventors to large multinational manufacturing companies. His practice includes patent preparation and prosecution, patent portfolio management, validity and infringement opinions, evaluations of new designs, and licensing strategy.  Nick graduated from the University of Oklahoma in 1987 with a B.S. in Petroleum Engineering, and received his J.D. from the University of Oklahoma College of Law in 1990. He is a member of the Intellectual Property Law Section of the Oklahoma Bar Association, and served as its president in 2006.

Doug Sorocco is listed in The Best Lawyers in America® 2016 in the field of Technology Law.  He practices in the areas of intellectual property, technology, licensing, life sciences and patent law and is involved in counseling and transactional work involving all aspects of intellectual property. He is registered to practice before the United States Patent and Trademark Office. Doug regularly counsels clients in all aspects of intellectual property including acquisition and commercialization of intellectual property, portfolio management, licensing and transactional matters. He is ranked in the top band of Oklahoma’s top intellectual property practitioners by the highly regarded Chambers USA: America’s Leading Lawyers for Business. Doug was also selected by attorney peers for inclusion in Oklahoma Super Lawyers–Rising Stars Edition (2010).  He is an adjunct faculty member at the Oklahoma City University School of Law and in the Physiology Department at the University of Oklahoma’s Health Sciences Center. 

Since its inception in 1983, Best Lawyers has become universally regarded as the definitive guide to legal excellence. Because Best Lawyers is based on an exhaustive peer–review survey on the legal abilities of other lawyers in their practice areas, and because lawyers are not required or allowed to pay a fee to be listed, inclusion in Best Lawyers is considered a singular honor. Corporate Counsel magazine has called Best Lawyers “the most respected referral list of attorneys in practice.” 

Dunlap Codding P.C., with offices in Austin, Chicago, Oklahoma City, Wilmington, and Washington, D.C., serves sophisticated international, national, and regional clients. Established in 1957 as Oklahoma’s original intellectual property firm, Dunlap Codding remains the state’s largest and most versatile IP boutique law firm.  

Dunlap Codding is a member of Primerus, an International Society of Law Firms.

Julie L. Langdon Selected As An Emerging Lawyer in Illinois
Posted Aug 13, 2015 at 10:38 am See More

Julie L. Langdon, a senior associate in Dunlap Codding’s Chicago office, has been selected as an Emerging Lawyer in Illinois by Leading Lawyers, a division of Law Bulletin Publishing Company, which recognizes the top two percent of lawyers who are under the age of 40 or who have been practicing law for fewer than ten years.  Julie’s practice encompasses a number of areas of intellectual property law, including litigation, licensing, counseling, and asset protection of copyrights, trademarks, patents, and trade secrets. Her primary practice is patent litigation with a concentration in the areas of biotechnology and life sciences, chemical, and pharmaceutical arts. Julie represents plaintiffs and defendants in patent-related litigations involving infringement and other disputes arising over patent rights.

Emily Campbell Quoted in Bloomberg BNA’s Patent, Trademark & Copyright Journal on Trademarks and Likelihood of Confusion
Posted Aug 11, 2015 at 13:54 pm See More

On August 7, Bloomberg BNA covered DC Comics v. Gotham City Networking, Inc., T.T.A.B., No. 91194716, 7/17/15.  The case involves a trademark application filed by Gotham City Networking Inc. for “Gotham Batmen” with a stylized bat-like logo to be used in networking referral services and “entertainment in the nature of amateur softball games.”  According to Bloomberg, “DC Comics, which owns the rights to Batman and numerous trademarks related to the superhero, opposed the registration on dilution and likelihood of confusion grounds.”  The Trademark Trial and Appeal Board ruled on July 17, that the use of the name “Gotham Batmen” was likely to cause confusion with a number of different marks owned by DC Comics.

Administrative Judge Jyll Taylor provided a dissenting opinion, noting that DC Comics had failed to establish that “Batman” was a famous mark, having not proven the connection between DC and Warner Bros. Studies.  According to BloombergBNA, “[t]he majority had found “Batman” to be famous, largely because of the films.

Gotham City argued that its trademark constituted a parody.  Dunlap Codding Shareholder Emily Campbell was quoted as saying that “for a parody defense to succeed in trademark law, the parodist has to walk a “fine line” between resembling the parodied mark and making a point…. [A] poster of a pregnant woman wearing a Girl Scout uniform with the Scouts’ slogan “Be Prepared” written underneath qualified as an example of an outrageous joke that worked as a trademark parody.”  She explained that the “Batman” –  “bat men” softball joke was not nearly as obvious and therefore did not bode well for Gotham City’s chances that its mark was a parody and would not cause confusion.

Campbell also said that Judge Taylor’s concerns were valid, and the majority’s famous mark analysis could be an issue on appeal.  “The dissent is interesting because there does seem to be a hole in the evidence.  The majority filled in the blanks to come to the conclusion that we all recognize the Batman name, but I think to adhere to the law [the board needed to make a fuller analysis.]”

Dunlap Codding Receives a Beacon Award for Charitable Influence
Posted Aug 11, 2015 at 8:44 am See More

Dunlap Codding was honored by The Journal Record, receiving a Beacon Award for Charitable Influence on July 17. The award recognizes organizations for demonstrating a company culture that encourages and supports volunteerism, charitable giving, and community involvement by its members.

Nearly all of Dunlap Codding’s team members dedicated their time and resources to charitable and community causes since 2013, when the firm began offering the use of DC on Film Row—an events and community space—to local creative, civic, and charitable organizations. In 2014 alone, the firm volunteered more than 1,000 hours and contributed $150,000 to hosting, supporting, and funding nearly 150 such events. 

Nicholas Rouse, the firm’s managing partner, said the firm started its civic and charitable work with the concept that “community doesn’t need a place, but it doesn’t hurt to have one.”  The Journal Record noted, “Dunlap Codding is redefining what it means to be actively engaged in the Oklahoma City community.”

One Year Anniversary of Alice
Posted Jun 30, 2015 at 11:36 am See More

Directors Marc Brockhaus and Jordan Sigale were guest bloggers on IP Frontline, a web magazine about intellectual property.  Our post, “What would Alice and its progreny look like as word jumbles?” ran on June 29, 2015. 

Managing Intellectual Property Ranks Dunlap Codding In Tier 1; Names Ip Stars
Posted Jun 25, 2015 at 12:10 pm See More

Dunlap Codding is pleased to announce that Managing Intellectual Property magazine ranked the firm in its top tier—Highly Recommended—and named five firm attorneys to its IP Stars 2015 list:  Marc A. Brockhaus, Nicholas D. Rouse, Jordan A. Sigale (Illinois), Douglas J. Sorocco, and Joseph P. Titterington.  More Dunlap Codding lawyers were named to the list of IP Stars than from any other firm in Oklahoma. 

Marc Brockhaus leads the firm’s Electrical Engineering & Systems group.  He received his J.D., M.B.A., and B.S. in Electrical Engineering from the University of Oklahoma.  Nick Rouse is the firm’s Managing Director and the head of its Mechanical Engineering group.  He received his J.D. and his B.S. in Petroleum Engineering from the University of Oklahoma.  Doug Sorocco heads the firm’s Life Sciences practice and received his J.D. from the University of Dayton and his B.S. in Chemistry from Butler University. Jordan Sigale is a Co-Chair of the firm’s Litigation practice and offices in Chicago.  He received his J.D., magna cum laude, and B.S. in Electrical and Computer Engineering from the University of Illinois.  Joe Titterington is also a Co-Chair of the firm’s Litigation practice.  He received his J.D. from the University of Oklahoma and his B.S. in Psychology from Oklahoma State University. 

Managing Intellectual Property’s IP Handbook ranks leading intellectual property agencies and law firms worldwide, highlighting the country’s prominent intellectual property attorneys.  Results are based on a research process comprising more than 1,000 interviews of and surveys from peers and in-house counsel active in the United States. 

Dunlap Codding Director Jordan A. Sigale Quoted in Articles Analyzing the U.S. Supreme Court’s Ruling in Kimble v. Marvel
Posted Jun 25, 2015 at 12:06 pm See More

Jordan A. Sigale was quoted in Donna Young’s recent article in Scrip Intelligence, “Patent ‘superpowers’ time limits upheld:  Biopharma implications.”  Young wrote that Kimble v. Marvel  “may help patent holders and those that enter into licensing rights deals, including biopharmaceutical makers, better understand and be more aware of a nearly half-century old case law rule.”  

The U.S. Supreme Court, in a split decision, declined to overturn the 1964 standard set in Brulotte v. Thys, which ruled that patent holders cannot demand royalties for the use of their inventions after the patent terms have expired. 

Sigale said, “Big biopharmaceutical firms are well-represented in patent law and intellectual property matters, so they already know their way around the Brulotte rule….If anything, the Supreme Court’s ruling in the Marvel case makes it clearer the Brulotte rule is narrow and that there are ways to draft around it….But for those who are unsophisticated about Brulotte, the opinion is unfortunate….It would be much better to knock out this rule.  It doesn’t make economic sense…and any standard that gives the advantage to those who can afford the best legal representation is bad for society.”

 Ryan Davis, writing for Law360, on June 22, 2015, also quoted Sigale.  Davis wrote, “The Kimble case arose because neither party knew about the [Brulotte] rule when Marvel agreed to license Kimble’s patent for use in a Spider-Man Web Blaster toy in perpetuity.”  Sigale was quoted as saying, “The decision explains that the Brulotte rule really is as narrow as we thought it was….If you make it clear there are no royalties for the patent after it expires, you can do anything you want.”  

“Sigale said it was helpful that the court expressly gave its blessing to later payments of royalties accrued during the life of the patent,” said Davis.  Sigale said, “Before today, people were a little nervous that the court would say that’s just putting form over substance.”

Dunlap Codding Senior Associate Julie L. Langdon Quoted in Law360—“6 Ways Associates Are Falling Short”
Posted Jun 2, 2015 at 13:36 pm See More

Julie Langdon was quoted by Cara Salvatore in an article published by Law360 on June 1, 2015, entitled “6 Ways Associates Are Falling Short.”  The article noted the following ways associates are stumbling and offered steps to improve:

  • They Aren’t Visible Enough
  • They Don’t Take Ownership
  • They’re Not Thorough
  • They’re Not Friend Material
  • They Don’t Know How to Talk on the Phone
  • They Don’t Sow the Seeds for Business Development

Discussing ownership, Langdon noted that it was important to follow up relentlessly and to know what to do when mistakes occur.   When they do, as they inevitably will,  it’s important to own the problem quickly and take steps to correct it.  “Unfortunately, it happens:  A document that was supposed to be filed under seal that was, by mistake, filed publicly, and you’re calling the clerk at 8 a.m. the next morning…’take this off the docket.’”  She went on to note, “All things are fixable.”

Jordan Sigale Quoted in Bloomberg BNA Article on Patents
Posted Jun 2, 2015 at 13:23 pm See More

“A belief that a patent is invalid isn’t a defense to a charge of induced infringement, the Supreme Court ruled 6-2 on May 26 (Commil USA, LLC v. Cisco Systems, Inc., 2015 BL 164427, U.S., No. 13-896, 5/25/15).”  Bloomberg writes that the Supreme Court reversed the Federal Circuit Court, holding that Cisco Systems Inc. couldn’t overturn a jury award based on its argument that Commil USA LLC’s Wi-Fi related patent claims were invalid.  A third trial is now likely in this case, according to Bloomberg, “The case returns to the Federal Circuit with only one part of its decision reversed.” 

Some commenters noted that the court’s comments on trolls were surprising, and opined that the decision likely increased the power of patent trolls.  Still others thought the ruling would bring an increase in patent litigation. 

Discussing the impact on litigation, Dunlap Codding Director Jordan A. Sigale, disappointed in the court’s decision, said, “There are some patents that are so overbroad and/or so ambiguous that it may be difficult to provide a reasonable opinion of non-infringement, whereas a reasonable (maybe even and clear and convincing) opinion of invalidity would be simple to write….Yet, this opinion would now be insufficient to avoid inducement liability under Commil.”

CLICK TO EXPAND

DC On Film Row

About DC on Film Row

DC on Film Row is a free event space open to everyone in our community.

We like to say that the space is a “home for creatives and innovators, home builders and the homeless, celebrators and the celebrated” so people understand that we are inclusive and want everyone from throughout our community using our space.

Our goal is to celebrate the incredible diversity of creativity, innovation, and passion within Oklahoma City and to provide a venue—free of charge—to those groups and individuals working to bind us all together and make our home a cooler and better place. No strings attached—no extensive rules to follow. We simply ask that all of our neighbors be honored and that all viewpoints be respected. Our criteria for use is simple: If the event, group, or meeting is something which strengthens our community and brings us all together, the space is available for use.

The space has hosted everything from charitable fundraisers to an underground nightclub party to celebrate Canterbury Choral Society’s 45th anniversary season. We host dinners for the OKC homeless population most Monday evenings where upwards of 250 people are served—we provide the space and soft drinks and a local church provides the food. We’ve hosted university planning retreats and monthly local rock concerts.

Every Wednesday, we open up the courtyard for lunch, invite a local food truck to set up outside our gates, and welcome our downtown neighbors into the space for a bit of socialization.

Our never-ending soda fountain seems to be the biggest hit with some of our neighbors while others spend time playing pool or simply chatting about what is happening on the weekend.

For October we turn the space into a haunted house and invite the neighborhood children to come out and trick-or-treat.

Got an idea for how to use the space? Just ask us – we’re almost certain to say yes!

Twitter Instagram Facebook

Industries Served

Biotechnology

LIFE SCIENCES AND BIOCHEMISTRY
Leveraging Patent Portfolios

Our professionals routinely assist legacy and start-up companies in the acquisition and exploitation of patent portfolios of cutting edge research in the areas of pharmaceuticals, drug formulation, medical technology, drug screening, inflammation inhibitors, regulation of skin pigmentation, testing for environmental pollution, novel treatments of septic shock, and water and food quality testing.  We have an exceptional track record in identifying and protecting inventions involving:

  • Pain regulation
  • Tissue grafting
  • Cloning/gene expression/protein production, isolation and characterization
  • Cell surface expressional
  • Medical/surgical anesthetic devices
  • Biocidal formulations and coatings
  • Toxicity screening
  • Enzymatic activity assays
  • Drug delivery systems
  • Developing Portfolio Strategy

We believe that a pragmatic and strategic approach is necessary to ensure that every portfolio is strong on defense as well as on offense. Whether it is a core, a platform, a fence-picket or a poker-chip technology, Dunlap Codding has the depth of experience and tools necessary to help our clients determine whether it is an asset or simply just an expense.

Chemistry and Chemicals

Chemistry is one of the fundamental foundations of science and technology. Emerging chemical research and experimentation continually produce innovations that shape the field of raw materials and affects the lives of every person on the planet.

Dunlap Codding is fortunate to work with and contribute to the success of many of the leading researchers and entrepreneurs in these areas. From nano-fibers to synthetic and recombinant polymers, Dunlap Codding consistently provides clients with broad-based, cost-effective patent prosecution in the chemical arts.

The depth of our skill and experience is unmatched in our region. We represent several of the largest chemical companies in the world and have shepherded the development of complex patent portfolios and transactional items.

Selected Clients

Invista S.a.r.l. is one of the world’s largest integrated fibers and polymers businesses. The company has a powerful portfolio of some of the most recognized global brands—Lycra®, Stainmaster®, Cordura®—for example. Built on a heritage of innovation, Invista owns more than 700 unique pending or granted U.S. patents, with corresponding patents in nearly all the countries where they have a business presence. We were honored to be one of Invista’s preferred providers of intellectual property services supporting their chemical intermediates and performance fiber initiatives. As part of these efforts, we wrote and prosecuted patents on hundreds of Invista technologies and provided strategic planning and facilitated innovation services to maintain Invista’s technological lead. Notably, Invista relied on our chemical engineering and chemistry expertise for transactional matters requiring complex reviews of freedom to operate, infringement, and invalidity concerns. Recently we provided Invista with the due diligence analysis and opinions required for the placement and construction of a chemical plan requiring a capital investment of more than $1 billion dollars.

Cristal USA Inc. is the United States arm of Cristal Arabia, one of the largest titanium dioxide and performance chemicals producers in the world. As part of our representation of Cristal, we are responsible for the strategic development and management of Cristal’s intellectual property portfolio, including the patent assets of Millennium Inorganic Chemicals—a wholly owned subsidiary of Cristal. Cristal and Millennium’s technologies encompass titanium dioxide, titanium metal, performance chemicals, and DeNOx technologies for removing nitrous oxide from the exhaust of internal combustion engines. We have developed a proprietary process for the identification of patenting opportunities, and use the process in facilitated sessions with technical and business personnel of Millennium. This proprietary process currently tracks more than 100 companies and approximately 1,000 intellectual property documents.

We work with DuPont Performance Elastomers to facilitate the development of new technologies and patenting strategies around DPE’s core elastomer technologies. In addition to such strategic planning, we provide assistance and guidance to DuPont’s in-house legal staff and technical champions.

Technology Focus:
Nanotechnology

We obtained multiple patent families for Dr. Daniel Resasco, a University of Oklahoma professor of chemical engineering. Dr. Resasco’s pioneering work in sulfur tolerant catalysts and nanotechnology resulted in the first method for making carbon nanotubes in commercial quantities.

Surface Technology

We represent international chemical companies such as SDC Technologies Inc., a world leader in the development and manufacturing of polymeric high-performance abrasion resistant coating systems for application to plastic and glass materials. Dunlap Codding helped SDC develop patent portfolios involving several chemical arts such as nanotechnology, material sciences, and state of the art functional surface coating technologies. SDC’s considerable patent portfolio secured its position as a world-wide industry leader providing the chemical marketplace with enhancements required for the materials of tomorrow.

Polymers

We work extensively with clients involved with polymers, polymeric coating compositions and resinous compositions having enhanced color, optical clarity, thermal shock, and impact resistance. Dunlap Codding obtained patent protection for Dr. William Franks’ innovative methods for polymerizing soybean oil. Dr. Franks’ methods led to the development of the first commercially available one hundred percent soybean oil based inks. Dunlap Codding also has expertise in the areas of petrochemicals and water repellent compositions for cellulose containing materials.

Environmental & Green Technologies

We have procured patent rights in various fields of environmental science. Dunlap Codding obtained patents for one of the first water-based inks that is completely free of volatile organic compounds. These inks are water-resistant upon curing and can be printed on polymer films. The inks have won numerous awards and accolades for the impact they have had on environmental quality and safety. Dunlap Codding was also privileged to successfully prosecute the patent that protects the state of the art technology for using sophisticated surfactants to remediate underground pollution. This new technology may also revolutionize the household detergent industry.

The challenges inherent in the specialized field of procuring and protecting chemical intellectual property rights mandate working with legal experts who are well versed in the chemical arts. Our diverse and knowledgeable team of patent attorneys and agents includes former research chemists with extensive chemical background at the doctoral level, a wealth of scientific knowledge gained from industry experience and a former corporate patent general counsel having responsibility for a chemical subsidiary of a major corporation.

Life Sciences

We provide the insight and practical advice required by innovative companies to compete effectively in the marketplace.

Over the past 20 years, life sciences, biotechnology, and pharmaceutical ventures set new records for research and capital investment. Just as the life sciences are the building blocks of life itself, new biotechnologies consistently push the intellectual property envelope, requiring highly specialized and focused representation. Dunlap Codding assists many of these emerging growth companies in the development of their business plans, as well as securing strategic life science patent portfolios that are used for offense as well as defense.

Our life sciences and pharmaceutical practice has grown with the evolving needs of our clients. This evolution is evident in the increased number of Ph.D. level scientists moving into the field of patent prosecution. Along with our experienced patent professionals, top caliber technical advisors having varied academic and industry backgrounds complete our Life Sciences and Pharmaceuticals Practice Group.

Our proficiencies are a reflection of our extensive legal and scientific backgrounds including Doctorate and other advanced degrees in Chemistry, Botany, Plant Physiology, Population, Biochemistry and Molecular Biology. We have also served as adjunct faculty members at several universities including the University of Oklahoma Health Sciences Center and Oklahoma City University School of Law.

Our clients benefit from our professionalism, efficiency, and devotion to their individual intellectual property needs. We provide advice and counseling to medical and biotechnology companies including high-tech startups, university laboratories, research institutions, and established biotechnology pioneers.

We provide the personal attention that results in successful patent portfolios. Dunlap Codding’s expertise extends into all areas of biotechnology including glycobiology, biochemistry, immunology, microbiology, virology, genetics, developmental biology, cell biology, molecular biology, pharmaceutical compositions, molecular diagnostics and techniques, and medical devices and equipment.

A Strategic Partnering Example—Medical Devices/Biotechnology
For a client with a medical device designed to maintain blood flow, we performed a complete state of the art search, analyzing more than 300 references. The current “map” contains more than 1,000 references—patent, technical, and literature.

  • We brainstormed with engineering, legal, business and marketing teams to develop a hierarchy of chokepoints and “white space.”
  • We facilitated innovation strategy meetings and currently maintain an online and proprietary database including visualization tools focused on the information collected and analyzed.
  • We helped the client develop a patent strategy with a specific goal of market entry.  Market entry was achieved within 18 months of project initiation.
Additional highlights of include:
Cutting Edge Biotechnology

We were instrumental in securing intellectual property protection for the first process for producing individual endogenously loaded soluble HLA molecules and on the first recombinant methods for producing hyaluronic acid, chondroitin, and heparin. These patent portfolios have led to the creation of five biotechnology companies in several Oklahoma and Texas metroplexes.

We were instrumental in securing broad platform intellectual property protection for preconditioning and treatment of an intrinsic cardiac nervous system using an implantable electrical stimulus.

Immunology

We secured pioneering intellectual property protection for the first process for producing individual endogenously loaded soluble major histocompatibility complex (MHC) molecules. Our deep experience and skill in this area also extends to methods and processes for producing T Cell Receptor-mimics (TCRm) and the use of such mimics for the creation of peptides and antibodies for use in vaccines as well as assaying the potency of vaccines. We are pleased to have represented more than 12 U.S. and/or international companies in the field of immunology and we prosecute more than 100 patent applications worldwide per year on immunology-linked inventions.

We also have specific knowledge and experience in the areas of immune modulation, including the induction of targeted immune responses and the induction of specific immune tolerance, and antibody removal for transplantation technologies.

Oncology

We treat the field of oncology with a multi-disciplinary approach. Most biochemical inventions either have or hope to have some impact on the field of oncology. As such, our approach is to create a team of professionals with diverse backgrounds who can effectively and proactively protect a client’s oncology innovations. For example, we prosecuted and obtained the patent portfolio covering the fire recombinant methods for producing hyaluronic acid, chondroitin, and heparin. These glycosaminoglycans show excellent promise for oncological applications and we have extended the portfolio to cover their use as therapeutic and diagnostic tools. Additionally, many of our immunology clients perform research in the field of oncologic therapeutics—including the use of antibodies, cytolytic delivery of peptides, or conjugates for the targeting and treatment of specific forms of cancer, as well as other methods of upregulating the immune system to recognize cancerous cells as foreign. We are also experienced in diagnostic oncologic technologies, including the use of biomarkers and other diagnostic platforms for identification, progression, metastasis and prognosis.